Biomedicine & Pharmacotherapy · 2021 · 43 citations · 39 references
Life SciencesBiotechnologyMolecular BiologyGenome EditingMolecular VirologyVirologyAntiviral TherapyCrispr-cas SystemsRna EditingRna InterferenceViral HepatitisVirus-induced Gene SilencingCrispr-cas13 SystemsDirect-acting Antiviral AgentsDirect-acting AntiviralsHepatitis C Virus ReplicationInternal Ribosome Entry Site (Ires) - Mediated TranslationInternal Ribosome Entry SitesResistance To Viral InfectionViral Therapeutic Targets
Hepatitis C is an inflammatory liver disease caused by the single-stranded RNA (ssRNA) hepatitis C virus (HCV). The genetic diversity of the virus and quasispecies produced during replication have resulted in viral resistance to direct-acting antivirals (DAAs) as well as impediments in vaccine development. The recent adaptation of CRISPR-Cas as an alternative antiviral approach has demonstrated degradation of viral nucleic acids in eukaryotes. In particular, the CRISPR-effector Cas13 enzyme has been shown to target ssRNA viruses effectively. In this work, we have employed Cas13a to knockdown HCV in mammalian cells. Using a computational screen, we identified several potential Cas13a target sites within highly conserved regions of the HCV internal ribosomal entry site (IRES). Our results demonstrate significant inhibition of HCV replication as well as translation in huh-7.5 cells with minimal effects on cell viability. These findings were validated using a multi-modality approach involving qRT-PCR, luciferase assay, and MTT cell viability assay. In conclusion, the CRISPR-Cas13a system efficiently targets HCV in vitro, suggesting its potential as a programmable therapeutic antiviral strategy.
39
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Stan J. J. Brouns, Matthijs M. Jore, Magnus Lundgren et al. · Science · 2008 · 2.6K citations · Full text
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Omar O. Abudayyeh, Jonathan S. Gootenberg, Silvana Konermann et al. · Science · 2016 · 2.4K citations · Full text
RNA-programmed genome editing in human cells
Martin Jínek, Alexandra East, Aaron Cheng et al. · eLife · 2013 · 2.2K citations · Full text
RNA targeting with CRISPR–Cas13
Omar O. Abudayyeh, Jonathan S. Gootenberg, Patrick Essletzbichler et al. · Nature · 2017 · 2.1K citations · Full text
CRISPR-Cas12a-assisted nucleic acid detection
Shiyuan Li, Qiuxiang Cheng, Jing-Man Wang et al. · Cell Discovery · 2018 · 1.5K citations · Full text